Literature DB >> 19237606

Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.

Stefan Michiels1, Agnès Laplanche, Thomas Boulet, Philippe Dessen, Bertrand Guillonneau, Arnaud Méjean, François Desgrandchamps, Mark Lathrop, Alain Sarasin, Simone Benhamou.   

Abstract

Several defense mechanisms have been developed and maintained during the evolution to protect human cells against damage produced from exogenous or endogenous sources. We examined the associations between bladder cancer and a panel of 652 polymorphisms from 85 genes involved in maintenance of genetic stability [base excision repair, nucleotide excision repair, double-strand break repair (DSBR) and mismatch repair, as well as DNA synthesis and cell cycle regulation pathways] in 201 incident bladder cancer cases and 326 hospital controls. Score statistics were used to test differences in haplotype frequencies between cases and controls in an unconditional logistic regression model. To account for multiple testing, we associated to each P-value the expected proportion of false discoveries (q-value). Haplotype analysis revealed significant associations (P < 0.01) between bladder cancer and two genes (POLB and FANCA) with an associated q-value of 24%. A permutation test was also used to determine whether, in each pathway analyzed, there are more variants whose allelic frequencies are different between cases and controls as compared with what would be expected by chance. Differences were found for cell cycle regulation (P = 0.02) and to a lesser extent for DSBR (P = 0.05) pathways. These results hint to a few potential candidate genes; however, our study was limited by the small sample size and therefore low statistical power to detect associations. It is anticipated that genome-wide association studies will open new perspectives for interpretation of the results of extensive candidate gene studies such as ours.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237606     DOI: 10.1093/carcin/bgp046

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

Review 1.  Targeting DNA polymerase ß for therapeutic intervention.

Authors:  Eva M Goellner; David Svilar; Karen H Almeida; Robert W Sobol
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium.

Authors:  Rémi Kazma; Marie-Claude Babron; Valérie Gaborieau; Emmanuelle Génin; Paul Brennan; Rayjean J Hung; John R McLaughlin; Hans E Krokan; Maiken B Elvestad; Frank Skorpen; Endre Anderssen; Tõnu Vooder; Kristjan Välk; Andres Metspalu; John K Field; Mark Lathrop; Alain Sarasin; Simone Benhamou
Journal:  Carcinogenesis       Date:  2012-03-01       Impact factor: 4.944

3.  Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai.

Authors:  Roman Corral; Juan Pablo Lewinger; David Van Den Berg; Amit D Joshi; Jian-Min Yuan; Manuela Gago-Dominguez; Victoria K Cortessis; Malcolm C Pike; David V Conti; Duncan C Thomas; Christopher K Edlund; Yu-Tang Gao; Yong-Bing Xiang; Wei Zhang; Yu-Chen Su; Mariana C Stern
Journal:  Int J Cancer       Date:  2014-01-13       Impact factor: 7.396

4.  Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.

Authors:  Sumati Gupta; Samantha Greenberg; Jade Grimmett; David Gaston; Neeraj Agarwal; William Lowrance; Joshua Schiffman; Wendy Kohlmann
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

5.  Statistical epistasis networks reduce the computational complexity of searching three-locus genetic models.

Authors:  Ting Hu; Angeline S Andrew; Margaret R Karagas; Jason H Moore
Journal:  Pac Symp Biocomput       Date:  2013

6.  Genome-wide association study identifies multiple loci associated with bladder cancer risk.

Authors:  Jonine D Figueroa; Yuanqing Ye; Afshan Siddiq; Montserrat Garcia-Closas; Nilanjan Chatterjee; Ludmila Prokunina-Olsson; Victoria K Cortessis; Charles Kooperberg; Olivier Cussenot; Simone Benhamou; Jennifer Prescott; Stefano Porru; Colin P Dinney; Núria Malats; Dalsu Baris; Mark Purdue; Eric J Jacobs; Demetrius Albanes; Zhaoming Wang; Xiang Deng; Charles C Chung; Wei Tang; H Bas Bueno-de-Mesquita; Dimitrios Trichopoulos; Börje Ljungberg; Françoise Clavel-Chapelon; Elisabete Weiderpass; Vittorio Krogh; Miren Dorronsoro; Ruth Travis; Anne Tjønneland; Paul Brenan; Jenny Chang-Claude; Elio Riboli; David Conti; Manuela Gago-Dominguez; Mariana C Stern; Malcolm C Pike; David Van Den Berg; Jian-Min Yuan; Chancellor Hohensee; Rebecca Rodabough; Geraldine Cancel-Tassin; Morgan Roupret; Eva Comperat; Constance Chen; Immaculata De Vivo; Edward Giovannucci; David J Hunter; Peter Kraft; Sara Lindstrom; Angela Carta; Sofia Pavanello; Cecilia Arici; Giuseppe Mastrangelo; Ashish M Kamat; Seth P Lerner; H Barton Grossman; Jie Lin; Jian Gu; Xia Pu; Amy Hutchinson; Laurie Burdette; William Wheeler; Manolis Kogevinas; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Molly Schwenn; Margaret R Karagas; Alison Johnson; Alan Schned; Karla R Armenti; G M Hosain; Gerald Andriole; Robert Grubb; Amanda Black; W Ryan Diver; Susan M Gapstur; Stephanie J Weinstein; Jarmo Virtamo; Chris A Haiman; Maria T Landi; Neil Caporaso; Joseph F Fraumeni; Paolo Vineis; Xifeng Wu; Debra T Silverman; Stephen Chanock; Nathaniel Rothman
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

7.  Gastrointestinal hyperplasia with altered expression of DNA polymerase beta.

Authors:  Katsuhiko Yoshizawa; Elena Jelezcova; Ashley R Brown; Julie F Foley; Abraham Nyska; Xiangli Cui; Lorne J Hofseth; Robert M Maronpot; Samuel H Wilson; Antonia R Sepulveda; Robert W Sobol
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

8.  Impact of reduced levels of APE1 transcripts on the survival of patients with urothelial carcinoma of the bladder.

Authors:  Mariana Chantre-Justino; Gilda Alves; Constança Britto; Angélica Cardoso; Luciano Scherrer; Aline dos Santos Moreira; Raul Quirino; Antonio Ornellas; Alvaro Leitão; Claudia Lage
Journal:  Oncol Rep       Date:  2015-07-24       Impact factor: 3.906

9.  The association between RAD23B Ala249Val polymorphism and cancer susceptibility: evidence from a meta-analysis.

Authors:  Zhenjun Li; Yan Zhang; Xiaojiang Ying; Junmin Song; Ruoxin Zhang; Zhen Li; Hongliang Chen; Pingjiang Ye; Yi Shen; Weihuo Pan; Zhiliang Chen
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

10.  Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case-control studies.

Authors:  Jie-Hui Zhong; Zhen Zhao; Jie Liu; Hai-Lang Yu; Jue-Yu Zhou; Rong Shi
Journal:  Onco Targets Ther       Date:  2016-03-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.